[HTML][HTML] Clinical Validation of the Myelofibrosis Transplant Scoring System in an Independent Series of Myelofibrosis Patients Undergoing Allogeneic Hematopoietic …

JG Correa, R de la Puerta, A Benzaquen, J Mora… - Blood, 2019 - Elsevier
Introduction: Allogeneic hematopoietic cell transplantation (allo-HCT) constitutes the only
curative treatment for myelofibrosis (MF), but its associated toxicity remains high. Prognostic …

[HTML][HTML] Predicting survival after allogeneic hematopoietic cell transplantation in myelofibrosis: performance of the Myelofibrosis Transplant Scoring System (MTSS) …

JC Hernández-Boluda, A Pereira… - Biology of Blood and …, 2020 - Elsevier
Accurate prognostic tools are crucial to assess the risk/benefit ratio of allogeneic
hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed …

Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation

N Gagelmann, M Ditschkowski… - Blood, The Journal …, 2019 - ashpublications.org
Allogeneic hematopoietic stem cell transplantation is curative in myelofibrosis, and current
prognostic scoring systems aim to select patients for transplantation. Here, we aimed to …

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

R Tamari, DP McLornan, KW Ahn… - Blood …, 2023 - ashpublications.org
To develop a prognostic model for patients undergoing allogeneic hematopoietic cell
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …

[HTML][HTML] Hematopoietic cell transplantation for myelofibrosis: the dynamic international prognostic scoring system plus risk predicts post-transplant outcomes

BTS Bannow, RB Salit, BE Storer, EA Stevens… - Biology of Blood and …, 2018 - Elsevier
Hematopoietic cell transplantation (HCT) provides potentially curative treatment for patients
with myelofibrosis (MF). HCT outcomes are associated with the Dynamic International …

Survival advantage to allogeneic transplant in patients with myelofibrosis with intermediate-1 or higher DIPSS score

KL Gowin, KK Ballen, K Woo Ahn, ZH Hu, Y Liu… - Blood, 2018 - ashpublications.org
Introduction: Allogeneic hematopoietic stem cell transplantation (HCT) is the only curative
therapy for myelofibrosis (MF). Consideration of HCT is recommended by international …

[HTML][HTML] Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic …

M Ditschkowski, AH Elmaagacli, R Trenschel… - …, 2012 - ncbi.nlm.nih.gov
Background Myelofibrosis is a myeloproliferative stem cell disorder curable exclusively by
allogeneic hematopoietic stem cell transplantation and is associated with substantial …

Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis

T Jain, KL Kunze, L Mountjoy, DK Partain… - Blood cancer …, 2020 - nature.com
Factors predicting allogeneic hematopoietic cell transplantation (HCT) outcomes in
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …

Survival following allogeneic transplant in patients with myelofibrosis

K Gowin, K Ballen, KW Ahn, ZH Hu, H Ali… - Blood …, 2020 - ashpublications.org
Allogeneic hematopoietic cell transplantation (HCT) is the only curative therapy for
myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF …

[HTML][HTML] Hematopoietic cell transplantation for myelofibrosis: dipss plus risk predicts post-transplant outcomes

BTS Bannow, RB Salit, BE Storer… - Biology of blood …, 2017 - pmc.ncbi.nlm.nih.gov
Hematopoietic cell transplantation (HCT) provides potentially curative treatment for patients
with myelofibrosis (MF). HCT outcomes are associated with the Dynamic International …